Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Phase II Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors

NCT02454972 is registered in ClinicalTrials.gov with PharmaMar as lead sponsor.

NCT NCT02454972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02454972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Phase II Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors
Lead sponsor
PharmaMar
Phase
Phase 2
Overall status
Completed
Start date
August 25, 2015
Completion date
September 18, 2020
Enrollment
345 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors